"Our mission is to provide the highest quality, most cost-effective gastroenterology care to our patients. We will have physicians of unsurpassed ability; Endoscopy centers equipped with the finest state-of-the-art equipment; a clinical staff delivering the best care in a comfortable, safe, and confidential environment; and an office staff providing helpful and compassionate services with patient satisfaction their first priority."

During the past decade, Gastroenterology Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gastroenterology Associates" #1 sponsor was "Ferring Pharmaceuticals" with 3 trials, followed by "Bausch Health Americas, Inc." with 2 trials sponsored, "Evoke Pharma" with 2 trials sponsored, "Tioga Pharmaceuticals" with 2 trials sponsored and "Dynogen Pharmaceuticals" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gastroenterology Associates" #1 collaborator was "RTI Health Solutions" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Gastroenterology Associates" are "Irritable Bowel Syndrome" (4 trials), "Colorectal Cancer" (2 trials), "Crohn's Disease" (2 trials), "Diabetic Gastroparesis" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Gastroenterology Associates" in a lesser frequency.

Most popular intervention types in "Gastroenterology Associates" are "Drug" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Asimadoline" (2 trials), "Metoclopramide Nasal Spray" (2 trials), "Placebo Nasal Spray" (2 trials) and "Semapimod" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gastroenterology Associates" are 10 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Gastroenterology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Gastroenterology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gastroenterology Associates, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".